Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors

Open Access

Peer-reviewed

Research Article

Peter G. Traber ,

* E-mail: traber@galectintherapeutics.com

Affiliations Galectin Therapeutics Inc, Norcross, Georgia, United States of America, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America
⨯
Eliezer Zomer

Affiliation Galectin Therapeutics Inc, Norcross, Georgia, United States of America
⨯

Reader Comments (0)

Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Collagens
Is the Subject Area "Collagens" applicable to this article?

Thanks for your feedback.
Fatty liver
Is the Subject Area "Fatty liver" applicable to this article?

Thanks for your feedback.
Fibrosis
Is the Subject Area "Fibrosis" applicable to this article?

Thanks for your feedback.
Macrophages
Is the Subject Area "Macrophages" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Hepatocytes
Is the Subject Area "Hepatocytes" applicable to this article?

Thanks for your feedback.
Fats
Is the Subject Area "Fats" applicable to this article?

Thanks for your feedback.